Potassium and magnesium asparaginate

Brand Pharmapol-Volga

In stock 729 Items

Available since: 2019-09-19

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Asparcam - a source of potassium and magnesium ions. Promotes the restoration of electrolyte balance. Potassium has an antiarrhythmic effect, supports normal heart activity. Magnesium is a cofactor of 300 enzyme reactions, promotes the penetration of potassium into the cells.

Indications

Hypokalemia and hypomagnesemia (including on the background caused emesis, diarrhea; saluretikami therapy, GCS and laxatives), accompanied by arrhythmias (including paroxysmal supraventricular tachycardia, atrial and ventricular extrasystoles) against digitalis intoxication, heart failure, or myocardial infarction.

Composition

1 tablet contains 175 mg of potassium aspartate and 175 mg of magnesium aspartate.

Potassium and magnesium asparaginate is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Asparcam	Pharmapol-Volga	Russia	pills
Panangin	Gedeon Richter	Hungary	pills
Asparcam	PFK Obnovlenie	Russia	pills
Asparcam	Irbit HFZ	Russia	pills
Panangin	Gedeon Richter	Hungary	ampoules
Panangin pills	Gedeon Richter	Hungary	pills
Asparcam	Pharmstandard	Russia	pills

No customer reviews for the moment.

Write your review

Dosage and Administration

Inside, usually for adults - 1-2 pills 3 times a day after meals. The course of treatment is 3-4 weeks. If necessary, it can be repeated.

Adverse reactions

Nausea, dizziness,
face redness,
thirst,
lowering blood pressure, hyporeflexia.
hyperkalemia (nausea, vomiting, diarrhea, paresthesia) and hypermagnemia (facial skin flushing, thirst, bradycardia, lowering blood pressure, muscle weakness, fatigue, paresis, coma, areflexia, respiratory depression, cramps)

Contraindications

Hypersensitivity to the drug Asparcam,
hyperkalemia,
hypermagnesium,
acute and chronic renal failure,
adrenal insufficiency,
atrioventricular block II and III,
cardiogenic shock,
oliguria - anuria,
acute metabolic acidosis,
severe myasthenia gravis
dehydration, addison's disease,
hypotension
pregnancy,
lactation period
age up to 18 years (efficacy and safety have not been established).

Drug interactions

Potassium-sparing diuretics (triamterene, spironolactone), beta-blockers, cyclosporine, heparin, angiotensin-converting enzyme inhibitors, nonsteroidal anti-inflammatory drugs - the risk of hyperkalemia, up to the development of arrhythmia and asystole.

Special instructions

No studies have been conducted to assess the effect of the drug on the ability to drive vehicles and to engage in other potentially hazardous activities that require increased concentration and psychomotor speed.